Physician

Marcus Johannes Geer, MD

According to 2025 Medicare claims, Marcus Geer, MD (NPI: 1164872537) practices hematology in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Montcalm, MI. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF MICHIGAN (NPI: 1881626265; TIN: 386006309) and primary practice location at 48109-5000. Geer is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Geer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 69 traditional Medicare patients, billed 408 HCPCS/CPT codes, and received $36,839 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 209 prescription claims across 39 beneficiaries totaling $84,820 in drug costs, led by Acyclovir (Acyclovir). Open Payments data shows 1 records totaling $60. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,102 to $84,820. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$18K$37K2023 Medicare payment: $8,157 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $36,839 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20232191$8,157
202469408$36,839

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$42K$85K2016 Drug cost: $4,102 (USD; Tot_Drug_Cst)2017 Drug cost: $17,962 (USD; Tot_Drug_Cst)2018 Drug cost: $56,316 (USD; Tot_Drug_Cst)2019 Drug cost: $71,046 (USD; Tot_Drug_Cst)2020 Drug cost: $12,528 (USD; Tot_Drug_Cst)2021 Drug cost: $13,208 (USD; Tot_Drug_Cst)2022 Drug cost: $12,823 (USD; Tot_Drug_Cst)2023 Drug cost: $52,095 (USD; Tot_Drug_Cst)2024 Drug cost: $84,820 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R64$4,102
201742375$17,962
201836395$56,316
201937418$71,046
20202555$12,528
20213795$13,208
20222438$12,823
20232683$52,095
202439209$84,820

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more45139$114
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes18149$95
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1420$74
G2212Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or1415$25
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's1248$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
AcyclovirAcyclovir231,125$570
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim201,496$74
LevofloxacinLevofloxacin12255$69

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$60AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marcus Johannes Geer, MD?

Tedicare shows public-source Medicare data for Marcus Johannes Geer, MD (NPI 1164872537), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marcus Johannes Geer, MD have ACO affiliation data?

Marcus Johannes Geer, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Marcus Johannes Geer, MD?

Marcus Johannes Geer, MD is linked to REGENTS OF THE UNIVERSITY OF MICHIGAN (billing NPI 1881626265) in the available physician profile data.

Does Marcus Johannes Geer, MD have Open Payments data?

Marcus Johannes Geer, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.